Cargando…

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD

BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Kate M, Safari, Abdollah, Tan, Wan C, Bourbeau, Jean, FitzGerald, J Mark, Sadatsafavi, Mohsen, study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD)
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296193/ https://www.ncbi.nlm.nih.gov/pubmed/30587954 http://dx.doi.org/10.2147/COPD.S184424

Ejemplares similares

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
por: Ng, Bryan, et al.
Publicado: (2019)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

The diagnostic performance of patient symptoms in screening for COPD
por: Johnson, Kate M., et al.
Publicado: (2018)

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
por: Najafzadeh, Mehdi, et al.
Publicado: (2012)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
por: Safari, Abdollah, et al.
Publicado: (2022)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Program and Abstracts from the Canadian Digestive Diseases Week™ 2016
por: Gastroenterology, Canadian Association of, et al.
Publicado: (2016)

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study
por: Tavakoli, Hamid, et al.
Publicado: (2018)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
por: Thorlund, Kristian, et al.
Publicado: (2014)

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2013)

Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2012)

Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study
por: Cherian, Mathew, et al.
Publicado: (2021)

Current recommendations for the treatment of mild asthma
por: Shahidi, Neal, et al.
Publicado: (2010)

Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)

IMplementing Predictive Analytics towards efficient COPD Treatments (IMPACT): protocol for a stepped-wedge cluster randomized impact study
por: Michaux, Kristina D., et al.
Publicado: (2023)

Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review
por: Bahadori, Katayoon, et al.
Publicado: (2007)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD
por: Zinellu, Angelo, et al.
Publicado: (2016)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality
por: Kendzerska, Tetyana, et al.
Publicado: (2017)

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
por: Tavakoli, Hamid, et al.
Publicado: (2019)

Beta-blocker use and COPD mortality: a systematic review and meta-analysis
por: Etminan, Mahyar, et al.
Publicado: (2012)

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
por: Soumagne, Thibaud, et al.
Publicado: (2020)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
por: Kato, Mahoto, et al.
Publicado: (2017)

The impact of comorbidities on productivity loss in asthma patients
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2016)

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
por: Alshabanat, A., et al.
Publicado: (2015)

Decision-making in Surgery or Active Surveillance for Low Risk Papillary Thyroid Cancer During the COVID-19 Pandemic
por: Sawka, Anna M., et al.
Publicado: (2021)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD
por: Koskela, Jukka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vue2n7di92acsojrrrd3qo6pru